NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDA E-017-2018-0-EP-03 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME EP National Stage 19714936.2 Issued
NIDA E-017-2018-0-PCT-02 BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME PCT PCT PCT/US2019/022701 Expired
NIDDK E-081-2019-0-US-01 Method For Improving Insulin Sensitivity US 62/919,496 Abandoned
NEI E-058-2018-0-CA-05 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS CA National Stage 3094078 Issued
NEI E-058-2018-0-PCT-02 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS PCT PCT PCT/US2019/022611 Expired
NEI E-058-2018-0-EP-06 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO
VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL
THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS 		EP National Stage 19714930.5 Pending
NLM E-124-2017-1-EP-02 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS EP National Stage 17764475.4 Pending
NIAID E-095-2019-0-US-01 HIV RNA VACCINES US 62/819,394 Abandoned
NCI E-210-2018-0-US-01 RECOMBINANT MOLECULES CONTAINING LINKER FOR ACTIVATION OF T CELLS AND THEIR USE IN IMMUNOTHERAPY US 62/819,386 Abandoned
NCI E-097-2018-0-PCT-02 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES PCT PCT PCT/US2019/022309 Expired
NIAID E-251-2016-0-US-04 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US National Stage 16/333,561 Abandoned
NCATS E-253-2017-0-CL-04 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME CL National Stage 2317-2020 Issued
NCATS E-253-2017-0-PCT-02 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2019/021434 Expired
NCI E-207-2017-1-US-01 ADAM17 BINDING MOLECULES AND USES THEREOF US 62/815,471 Abandoned
NHLBI E-085-2019-0-US-01 MEASUREMENT OF NON-EXCHANGEABLE FLUORESCENT PHOSPHATIDYLETHANOLAMINE TRANSFER FROM DONOR PARTICLES TO PLASMA HDL TO ASSESS CARDIOVASCULAR DISEASE RISK US 62/815,604 Abandoned
NCI E-081-2018-0-PCT-02 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER PCT PCT PCT/US2019/020989 Expired
NCI E-157-2017-0-PCT-02 METHODS OF PREPARING POPULATIONS OF CELLS AND RETROVIRAL REAGENTS FOR ADOPTIVE CELL IMMUNOTHERAPY PCT PCT PCT/US2019/020903 Expired
NHLBI E-218-2016-1-PCT-02 Immunogens, Compositions, And Methods For Treating Dyslipidemia PCT PCT PCT/US2019/020900 Expired
NINDS E-025-2018-1-PCT-01 POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF PCT PCT COMB PCT/US2019/020896 Expired
NIAID E-145-2011-0-US-14 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 16/292,722 10869865 Issued PDF
NINDS E-309-2009-1-US-08 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US DIV 16/291,731 11324840 Issued PDF
NCI E-141-2008-0-US-34 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US CON 16/291,561 11110150 Issued PDF
NEI E-091-2018-0-EP-04 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION EP National Stage 19711759.1 Issued
NEI E-091-2018-0-GB-09 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION GB EP 19711759.1 Issued
NEI E-091-2018-0-DE-08 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION DE EP 19711759.1 Issued
NEI E-091-2018-0-FR-07 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION FR EP 19711759.1 Issued
NEI E-091-2018-0-JP-05 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION JP National Stage 2020-545170 Issued
NCATS E-757-2013-2-US-06 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS US CON 16/289,994 10752581 Issued PDF
NEI E-091-2018-0-PCT-02 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION PCT PCT PCT/US2019/020341 Expired
NCATS E-117-2018-0-PCT-02 DISCOVERY OF 2,6-DIMETHOXY-4-(5-PHENYL-4-THIOPHENE-2-YL-1H-IMIDAZOL-2-YL)-PHENOL (DPTIP) A SMALL MOLECULE INHIBITOR OF NEUTRAL SPHINGOMYELINASE 2 (nSMase-2) FOR THE TREATMENT OF NEURODEGENERATIVE AND ONCOLOGIC DISEASES PCT PCT PCT/US2019/020254 Expired
NCATS E-077-2020-1-US-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US 62/812,954 Expired
NCATS E-077-2020-0-US-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US 62/812,948 Expired
NEI E-091-2018-0-CA-03 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION CA National Stage 3091810 Pending
NIAID E-228-2016-1-IL-09 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof IL National Stage 265121 Issued
NIDDK E-742-2013-0-CN-08 A3 Adenosine Receptor Agonists CN DIV 201910154562.4 Issued
NIAID E-228-2016-1-US-02 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US National Stage 16/329,592 11338033 Issued PDF
NIAID E-099-2016-0-US-17 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/288,630 10946048 Abandoned PDF
NCI E-175-2016-0-KR-10 ANTI-KRAS-G12D T CELL RECEPTORS KR National Stage 10-2019-7005837 Issued
NIAID E-168-2016-0-US-03 METHOD AND COMPOSITION FOR OPTICAL CLEARING OF TISSUES US National Stage 16/328,553 1148-05-02 Issued PDF
NINDS E-235-2014-1-US-04 BIOMARKERS FOR DIAGNOSIS AND MANAGEMENT OF NEURO-IMMUNOLOGICAL DISEASES US DIV 16/284,914 10877049 Issued PDF
NHLBI E-029-2018-0-PCT-02 FAST MICRO TOMOGRAPHY SCANNER AND METHODS THEREOF PCT PCT PCT/US2019/019386 Abandoned
NIBIB E-054-2018-0-AU-08 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER AU National Stage 2019225154 Issued
NIBIB E-054-2018-0-HK-12 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER HK CN 62020019110.9 Issued
NIBIB E-054-2018-0-CN-03 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER CN National Stage 201980014834.9 Issued
NIBIB E-054-2018-0-JP-10 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER JP National Stage 2020-543529 Issued
NCI E-494-2013-0-RU-12 Methods of Preparing Anti-human Papillomavirus Antigen T Cells RU DIV 2019105050 Issued
NIDA E-073-2013-0-US-09 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US DIV 16/282,894 10913711 Issued PDF
NIBIB E-054-2018-0-PCT-02 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER PCT PCT PCT/US2019/019140 Expired
NIAID E-085-2018-0-PCT-02 CD153 AND/OR CD30 IN INFECTION PCT PCT PCT/US2019/019164 Expired
NIBIB E-054-2018-0-GB-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER GB National Stage 19756548.4 Pending